Loading...
XSHG
603880
Market cap306mUSD
Jul 10, Last price  
7.10CNY
1D
-1.39%
1Q
8.73%
IPO
9.20%
Name

Jiangsu Nanfang Medical Co Ltd

Chart & Performance

D1W1MN
XSHG:603880 chart
P/E
P/S
3.43
EPS
Div Yield, %
Shrs. gr., 5y
0.19%
Rev. gr., 5y
-11.01%
Revenues
599m
-0.67%
424,621,054510,798,291469,803,419433,022,478444,235,500488,708,743479,823,815491,688,0101,072,399,917527,440,661545,369,151600,095,343602,615,332598,581,792
Net income
-102m
L-46.66%
35,767,10348,044,64553,380,20351,242,69151,980,39447,601,36939,250,12428,051,59898,067,619-22,762,006-14,648,703-147,417,265-190,668,975-101,710,550
CFO
55m
-12.71%
76,074,46920,142,29873,518,72690,664,00699,350,00049,236,92652,749,49232,994,069154,122,592031,276,44815,509,53263,320,49755,273,644
Dividend
May 21, 20210.11539 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1990 in Changzhou, China, Jiangsu Nanfang Medical Co., Ltd. is dedicated to the innovation, production, and worldwide distribution of a comprehensive range of medical and healthcare products. Their offerings span transdermal solutions, specialized medical textiles, various adhesive tapes, bandages, sports injury prevention items, first-aid essentials, and personal care products. The company's extensive inventory includes a variety of medical and surgical adhesive tapes, advanced wound care dressings, and specialized plasters like capsicum, corn removal, and waterproof options. They also provide therapeutic products such as physical therapy and kinesiology tapes, rigid sports tapes, pain relief patches and sleeves, medical eye pads, elastic stretch tapes, and zinc oxide adhesive plasters, in addition to masks and custom-made solutions.
IPO date
Aug 07, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT